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Abstract
Background: Obesity has a strong genetic influence, with some variants showing stronger associations among
women than men. Women are also more likely to distribute weight in the abdomen following menopause. We
investigated whether genetic loci link with obesity-related phenotypes differently by menopausal status.
Methods: We performed univariate and bivariate linkage analysis for the phenotypes of body mass index (BMI),
waist (W) and hip (H) circumferences (WC, HC), and WH ratio (WHR) separately among 172 pre-menopausal and
405 post-menopausal women from 90 multigenerational families using a genome scan with 403 microsatellite
markers. Bivariate analysis used pair-wise combinations of obesity phenotypes to detect linkage at loci with
pleiotropic effects for genetically correlated traits. BMI was adjusted in models of WC, HC and WHR.
Results: Pre-menopausal women, compared to post-menopausal women, had higher heritability for BMI (h
2 = 94%
versus h
2 = 39%, respectively) and for HC (h
2 = 99% versus h
2 = 43%, respectively), and lower heritability for WC
(h
2 = 29% versus h
2 = 61%, respectively) and for WHR (h
2 = 39% versus h
2 = 57%, respectively). Among pre-
menopausal women, the strongest evidence for linkage was for the combination of BMI and HC traits at 3p26
(bivariate LOD = 3.65) and at 13q13-q14 (bivariate LOD = 3.59). Among post-menopausal women, the highest level
of evidence for genetic linkage was for HC at 4p15.3 (univariate LOD = 2.70) and 14q13 (univariate LOD = 2.51).
WC was not clearly linked to any locus.
Conclusions: These results support a genetic basis for fat deposition that differs by menopausal status, and
suggest that the same loci encode genes that influence general obesity (BMI) and HC, specifically, among pre-
menopausal women. However, lower heritability among pre-menopausal women for WC and WHR suggests that
pre-menopausal waist girth may be influenced to a greater extent by controllable environmental factors than post-
menopausal waist girth. Possibly, targeted interventions for weight control among pre-menopausal women may
prevent or attenuate post-menopausal abdominal weight deposition.
Background
Over the past 25 years, the prevalence of overweight
adults increased by 40% and that of obese adults by
almost 2-fold in the United States [1]. Together, over-
weight and obese adults account for 68% of Americans
[2]. Global increases in weight gain have also been
reported [3], and mirror the rise in obesity-related
chronic diseases including type 2 diabetes, cardiovascu-
lar diseases [4], and several cancers [5].
The rapid increases in overweight and obesity are
multi-factorial and only partly attributable to changes in
lifestyle practices [4]. Results from transgenic and
crossbred animal models and population-based studies
(reviewed in [6]), and more recently genome-wide asso-
ciation studies (GWAS) [7-14], provide strong evidence
for genetic influences on obesity-related phenotypes,
including overall weight gain and body fat distribution.
Although family and twin studies estimate that 40-70%
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measure of overall adiposity, is due to genetic factors
[15,16], genetic variants identified from the GWAS
account for < 1% of the variance of BMI in those sub-
jects [12,13], leaving a large proportion of the genetic
variation unexplained.
Body fat distribution may be more important than
overall adiposity on health [17]. Visceral abdominal fat
composed of omental and mesenteric adipocytes is
more metabolically active than subcutaneous fat [18],
secreting a variety of cytokines and inflammatory agents
with immunological, vascular, and metabolic actions
[19]. Previous studies showed that health risks are posi-
tively associated with waist circumference but inversely
related to hip circumference after adjustment for poten-
tial confounders [20,21]. Body composition changes
occur frequently among women following menopause,
in whom age-related increases in obesity occur more
often [22]. Observations based on objective assessments
of body composition such as CT scans noted increased
visceral fat deposition in post-menopausal compared to
pre-menopausal women [23]. Changes in body fat distri-
bution during the menopausal transition have also been
demonstrated longitudinally [24,25], including an abso-
lute cumulative 6-year increase of approximately 5.7 cm
in waist circumference [24]. Estrogen treatment has
been shown to prevent the increase in intra-abdominal
fat [26,27]. Possibly, the genetic determinants of abdom-
inal fat deposition and its metabolic sequelae may differ
from those that determine hip deposition of fat.
To our knowledge, no studies have examined genetic
determinants of obesity among pre-menopausal and
post-menopausal women separately. Because these
groups appear to have different propensities for fat
deposition, we used linkage analysis to test the hypoth-
esis that obesity-related phenotypes are influenced by
different genetic loci among pre-menopausal and post-
menopausal women using data from the Minnesota
Breast Cancer Family Study.
Methods
Study Population
The study was approved by the Institutional Review
Boards at the University of Minnesota and Mayo Clinic
and informed written consent was obtained from all
participants. Details of the study design and methods
have been published [28]. Briefly, breast cancer pro-
bands (n = 544) were ascertained at the Tumor Clinic
of the University of Minnesota Hospital in 1944. A fol-
low-up study was initiated in 1990 and telephone inter-
views detailed four-generation pedigrees of the probands
and eligible sisters, daughters, nieces and granddaugh-
ters of the probands and women identified as the spouse
of corresponding male first- and second-degree relatives
of the probands. Interviews were attempted with 6,664
living female relatives 18 years of age (426 of the 544
families), and 6,194 (93% response) consented.
Questionnaire Data
The telephone interview collected information on his-
tory of cancer, weight history, marital status, education,
occupational class, medical history, reproductive history,
oral contraceptive use, physical activity and history of
smoking and alcohol intake. Menopausal status was
determined from the response to a question of whether
the participant had a menstrual period within the last
year, excluding those brought on by hormones. Subjects
were mailed a body measurement questionnaire that
asked for replicated measures of current height and
weight. Circumferences of the waist (2 inches above the
umbilicus) and hips (maximal protrusion) were also
obtained using a validated protocol [29].
Subject Inclusion
The present study sample includes self-reported Cauca-
sian women from 90 of 426 families with the most
informative pedigrees chosen from simulation analysis,
excluding the probands with breast cancer [28]. After
the exclusion of 13 individuals due to consistent Mende-
lian errors across all markers, 889 individuals (756
women and 133 men) for whom we had blood-based
DNA formed the basis of the genome screen. Males
were excluded from analyses, although their genotypes
were used in linkage analyses for determination of iden-
tity by descent (IBD) and to infer genotypes on female
family members with missing DNA. The final sample
consisted of 577 women who completed the telephone
interview, returned the body measurement questionnaire
and provided a DNA sample.
Genotyping
DNA was genotyped for 403 microsatellite markers
across the genome in the Mayo Clinic Cancer Center’s
Genotyping Shared Resource according to conditions
suggested in the ABI Prism Linkage Mapping Set (PE
Applied Biosystems, version 2.5, Foster City, CA). Geno-
types were scored using an ABI 3100 or ABI 3730 DNA
sequencer and ABI Genotyper v3.7 or ABI Genemapper
v3.5 software. The average heterozygosity per marker
was 0.77 and the average inter-marker distance was
8.9 cM. Of 361,021 called genotypes, 357,172 (98.9%)
were Mendelian-consistent and used in analysis.
Statistical analysis
To satisfy the normality assumptions required by
variance components linkage analysis, we applied the
t-rank transformation to the distributions of waist and
hip circumferences and BMI; WHR was left
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ariates with known or suspected influence on obesity
phenotypes [30] were examined separately by menopau-
sal status using univariate regression and backward
elimination regression models with retention P values <
0.10 (SAS Institute, Cary, NC); both approaches identi-
fied similar non-genetic covariates for the final models.
We adjusted for age (continuous), parity (0, 1-2, or > 2
births), education (less than high school, some college,
or college graduate), smoking (never, former smoker
w i t h<2 0p a c ky e a r s ,f o r m e rs m o k e rw i t h≥ 20 pack
years, current smoker with < 20 pack years, or current
smokers with ≥ 20 pack years), physical activity (low,
moderate, or high), and oophorectomy (no, one ovary or
both removed). Since BMI is a measure of overall obe-
sity, it was included in the models of waist or hip cir-
cumference and WHR to better isolate the genetic
influences on body fat deposition in the waist and hip
areas. BMI was defined in kg/m
2. Because BMI was not
normally distributed, we included the inverse (1/BMI) in
continuous format in statistical models.
Multipoint IBD sharing probabilities were estimated in
SIMWALK2 [31]. Heritability between the transformed
and covariate-adjusted trait values was estimated with
variance decomposition using maximum likelihood
methods [32]. Univariate variance components linkage
analysis was performed using the R library MULTIC
[33,34] and a Fisher scoring algorithm to estimate
genetic parameters while also adjusting for covariates.
Genotype information at a locus was characterized by
the probability that two related individuals share none,
one, or two alleles IBD. Linkage was tested by a likeli-
hood ratio test for the hypothesis that the QTL variance
component is equal to zero compared with it being
greater than zero [35]. The data were analyzed using no
ascertainment correction because the phenotypes of
interest did not lead to the ascertainment of the
families. Univariate logarithm of odds (LOD) scores ≥
2 . 0w e r ec o n s i d e r e ds u g g e s t i v ea n dL O Ds c o r e s≥ 3.3
were considered significant [36].
Multivariate variance component analyses have been
shown to improve power to detect linkage over univariate
procedures at loci with pleiotropic effects for genetically
correlated phenotypes [37]. Evidence to support pleio-
tropy for obesity-related phenotypes in the current analy-
s i si n c l u d e st h es t r o n ga s s o c i a t i o na tLYPLAL1 among
women for both BMI and WHR [14]. We, therefore, per-
formed bivariate linkage analyses using pair-wise combi-
nations of obesity-related traits. Due to the greater
degrees of freedom, higher LOD score thresholds are
required to achieve comparable levels of statistical signifi-
cance (e.g., ≥ 3.0 was considered suggestive and those ≥
4.0 were considered significant) [36]. We performed mul-
tiple univariate and bivariate linkage analyses (these are
multiple phenotypes and should not be confused with
multiple testing). The LOD scores and corresponding
P values serve chiefly to indicate the relative strength of
evidence in favor of linkage. Similarly, when the bivariate
LOD scores met the bivariate LOD score criteria for link-
age, strength of the evidence in favor of pleiotropy was
inferred if the bivariate P value was as small as or smaller
than the component univariate P values.
Results
Post-menopausal women were older, heavier and had
greater waist circumference than pre-menopausal
women, although no substantial difference was noted in
hip circumference (Table 1). Among post-menopausal
women, current users of hormones were, on average,
younger (59.2 years, n = 138) than never (65.6 years, n
= 193) or former (66.3 years, n = 74) hormone users. In
age-adjusted analyses, current hormone users did not
have significantly different WHR (P =0 . 1 0 ) ,B M I( P =
0.13), and waist (P =0 . 0 9 )o rh i p( P = 0.25) circumfer-
ences than former or never hormone users (data not
shown). Heritability of obesity traits was significantly
greater than 0 (P < 0.001) for all estimates except waist
circumference (P =0 . 1 1 )a n dW H R( P =0 . 0 5 )a m o n g
pre-menopausal women (Table 2), suggesting most of
the variation observed in these two phenotypes among
pre-menopausal women is due to environmental and
not genetic influences. Pre-menopausal women com-
pared to post-menopausal women had higher heritability
for BMI (h
2 =9 4 %v e r s u sh
2 = 39%, respectively) and
for hip circumference (h
2 =9 9 %v e r s u sh
2 = 43%,
respectively), and lower heritability for waist circumfer-
ence (h
2 =2 9 %v e r s u sh
2 = 61%, respectively) and for
WHR (h
2 = 39% versus h
2 = 57%, respectively). The
high heritability of 99% for hip circumference among
pre-menopausal women is likely an upper bound esti-
mate. To verify this, we re-ran the hip circumference
model among pre-menopausal women without any
adjustment for covariates and observed h
2 =8 3 %( s t a n -
dard error = 0.11; data not shown). This indicates that
hip circumference has a very strong polygenic heritabil-
ity in pre-menopausal women.
For the BMI phenotype, the highest level of evidence
for genetic linkage was achieved on chromosomes 2p21-
p22 and 3p26 among pre-menopausal women, based on
LOD scores satisfying suggestive evidence (e.g., LOD =
2.89 and 2.90, respectively) (Table 3 and Figure 1). For
the hip circumference trait, the highest level of evidence
for genetic linkage was achieved on chromosome 13q13
among pre-menopausal women (LOD = 2.87) and on
chromosome 4p15.3 among post-menopausal women
(LOD = 2.70) (Table 3 and Figure 2). The WHR trait
also showed suggestive evidence for linkage among pre-
menopausal women on chromosome 1q21 (Table 3).
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dence (LOD ≥ 3.0) for 12 loci with pleiotropic effects on
pairwise combinations of obesity traits (Table 4). The
strongest evidence was among pre-menopausal women
on chromosomes 3 and 13, where the bivariate LOD
scores for the combination of BMI and hip circumfer-
ence traits were 3.65 at 3p26 and 3.59 at 13q13-q14
(Figure 3A and 3B). The bivariate genetic correlations
between these two traits were 0.85 at 3p26 and 0.53 at
13q13-q14 (data not shown). Among post-menopausal
women, there was no evidence of loci with pleiotropic
effects as indicated by LOD scores ≥ 3.00 on pairwise
combinations of obesity traits.
Discussion
Over 250 QTL for human obesity-related phenotypes
have been published from over 61 genome-wide scans
[6] and from over 10 GWAS http://www.genome.gov/
GWAStudies. Only a minority of these, however, exam-
ined WHR, waist circumference or hip circumference
phenotypes [9,14,38] and, to our knowledge, none pub-
lished on the genetic regulation of fat deposition in
women by menopausal status.
Early observations reported increased visceral fat in
post-menopausal compared to pre-menopausal women
independent of age using objective assessments of body
composition such as CT scans [23]. Samaras and collea-
gues [39] measured total and central fat using dual-
energy X-ray absorptiometry (DEXA) among 216
post-menopausal twin pairs. They reported heritability
estimates of 56% for total fat and 64% for central fat
that did not appear to be explained by the same genetic
factors, suggesting the two traits are regulated indepen-
dently. Pre-menopausal women were not studied. We
report similar heritability estimates among post-meno-
pausal women in our study for waist circumference (h
2
= 61%) and provide additional evidence that heritability
for this trait is lower, and not statistically significant,
among pre-menopausal women (h
2 = 29%). These
observations support two conclusions. First, low herit-
ability for waist circumference (and for WHR) among
pre-menopausal women suggests most of the phenotypic
variance is due to environmental influences. Second, the
higher heritability for these two phenotypes among
post-menopausal women suggests additive genetic fac-
tors explain a significantly larger proportion of the
inter-individual variation. If true, then interventions that
modify environmental contributions to abdominal fat
distribution (e.g., increased physical activity, decreased
total energy consumption) should target women in their
pre-menopausal years, when such interventions may be
more effective.
The heritability for hip circumference among pre-
menopausal women (h
2 = 99%) is much larger than
among post-menopausal women (h
2 = 43%). Along with
higher heritability for hip circumference among pre-
menopausal women, we also found suggestive evidence
for linkage. We showed that the phenotypes of BMI and
hip circumference were linked to the same loci at chro-
mosome 2p21-p22, chromosome 3p26, and chromosome
13q13-q14. The high genetic correlation between these
traits and their linkage to the same chromosomal
Table 1 Descriptive characteristics among women in the Minnesota Family Study
Variable
a Pre-menopausal women (n = 172) Post-menopausal women (n = 405)
Age, years 42 (36-47) 63 (57-70)
BMI
b, kg/m
2 24.8 (21.9-29.3) 25.6 (23.1-29.1)
WHR
c 0.79 (0.75-0.84) 0.85 (0.79-0.89)
Waist circumference, inches 31.0 (28.4-35.7) 34.0 (30.7-38.0)
Hip circumference, inches 39.7 (37.1-43.0) 40.0 (38.0-43.0)
aMedian (25th and 75th percentiles).
bBody mass index.
cWaist to hip ratio.
Table 2 Heritability estimates
a for obesity-related traits among women in the Minnesota Family Study
Obesity trait
b Pre-menopausal women (n = 172) Post-menopausal women (n = 405)
BMI 0.94 0.39
WHR 0.38 0.57
Waist circumference 0.29 0.61
Hip circumference 0.99 0.43
aHeritability is the proportion of interindividual phenotypic variance explained by additive genetic factors, measured on a scale from 0 to 1. Heritability estimates
were significantly greater than 0 (P < 0.001) except waist circumference (P = 0.11) and WHR (P = 0.05) among pre-menopausal women. Obesity traits were
adjusted for age, parity, education, smoking, physical activity, and oophorectomy. BMI was not adjusted in model estimates of heritability.
bBMI, body mass index; WHR, waist to hip ratio.
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pleiotropic effects of these loci among pre-menopausal
women. Because BMI is a ratio measure of weight and
height, we cannot rule out that some of the linkage at
regions 2p22-2p23 and 13q14 is with the height pheno-
type, as reported by several GWAS of height http://
www.genome.gov/GWAStudies. In contrast, there was
no evidence for pleiotropy among post-menopausal
women; however, the hip circumference trait showed
evidence of linkage to chromosome 4p15.3 and chromo-
some 14q13 indicating the influence of independent
loci. Although we found higher heritability for waist
Table 3 Univariate multivariable-adjusted
a multipoint linkage (LOD ≥ 2.0) at chromosomal regions with obesity-
related traits
Sample Position Trait
b Peak
LOD
score
Marker
closest
to peak
LOD
score
Genetic
map
distance
of
marker
(cM)
c
Physical
map
position
of marker
(bp)
d
Marker
interval
of
marker
closest
to peak
LOD
score
Physical
map
position of
marker
interval
(bp)
d
Nearest
gene on
genome
to
marker
Physical
map
position
of nearest
gene on
genome
(bp)
Nearest
gene
previously
reported
with trait
Physical
position of
nearest
gene
previously
reported
with trait
(bp)
d
Pre-
menopausal
1q21 WHR 2.09 D1S498 143.75 149,568,120 D1S252-
D1S484
117,358,294-
159,034,332
PI4KB 149,531,037 LYPLAL1
e 217,413,846
RASAL2
e 176,330,253
2p21-
p22
BMI 2.89 D2S2259 68.78 42,850,051 D2S367-
D2S391
34,294,652-
46,265,269
HAAO 42,847,734 TMEM18
e 657,975
3p26 BMI 2.90 D3S1297 14.83 2,013,403 D3S1297-
D3S1304
2,013,403-
6,894,583
CNTN4 2,117,247 GHRL
f
PPARG
f
10,302,434
12,304,349
3p26 BMI 2.90 D3S1304 14.83 6,894,242 D3S1297-
D3S1263
2,013,403-
11,492,535
GRM7 6,877,927 GHRL
f
PPARG
f
10,302,434
12,304,349
13q13 HC 2.87 D13S218 34.15 37,930,231 D3S2338-
D3S1266
16,824,399-
27,932,698
UFM1 37,822,018 HTR2A
f 46,305,514
13q14 BMI 2.60 D13S263 44.42 40,978,920 D13S218-
D13S153
37,930,231-
47,789,009
C13orf15
(RGC32)
40,929,712 HTR2A
f 46,305,514
13q14 BMI 2.60 D13S153 44.42 47,788,735 D13S263-
D13S156
40,978,920-
73,555,776
RB1 47,775,884 HTR2A
f 46,305,514
Post-
menopausal
4p15.3 HC 2.70 D4S403 25.0 13,359,926 D4S2935-
D4S419
6,611,782-
18,458,207
BOD1L 13,179,464 GNPDA2
e 44,398,926
5q21 HC 2.01 D5S433 115.1 103,990,522 D5S644-
D5S2027
95,838,450-
111,173,613
None
g CARTPT
f
NR3C1
f
ADRB2
f
71,050,750
142,637,689
148,186,349
5q22 HC 2.01 D5S2027 115.1 111,173,318 D5S433-
D5S471
103,990,522-
119,077,177
STARD4 110,861,921 CARTPT
f
NR3C1
f
ADRB2
f
71,050,750
142,637,689
148,186,349
14q13 HC 2.51 D14S70 34.15 33,528,945 D14S275-
D14S288
25,766,613-
43,171,795
EGLN3 33,463,174 ESR2
f 30,234,561
aAdjusted for age, parity, education, smoking, physical activity, and oophorectomy. BMI was included in the models of waist circumference and WHR, and of hip
circumference and WHR.
bBMI, body mass index; WHR, waist to hip ratio; HC, hip circumference.
cGenetic map distance in centimorgans (cM) is the position of genetic markers relative to each other along a chromosome in terms of recombination frequency,
rather than as specific physical distance. One cM represents approximately 1% recombination frequency. The greater the recombination frequency between two
genetic markers along a chromosome, the farther apart physically they are assumed to be.
dHapMap Genome Browser, NCBI Build 36.
eFrom genome-wide association studies.
fFrom linkage studies.
gNone within 500 kb.
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pared to pre-menopausal women, we did not find evi-
dence for linkage with waist circumference at loci in
either of the two groups of women. Reasons for this
might include allelic effects that are smaller or causal
alleles that are too rare to detect with the given sample
size [40], or confounding by unaccounted environmental
influences. For instance, if the resemblance of first-
degree family members is partly due to common envir-
onmental effects, then an estimate of heritability that is
based on their resemblance will be biased upwards [41].
However, our heritability estimate for waist circumfer-
ence among post-menopausal women was similar to
that reported by Samaras and colleagues [39], and the
circumferences in this analysis were based on actual
measurements that have been shown to be obtained reli-
ably and with good precision [29].
To our knowledge, only two GWAS reported obesity
phenotype associations separately by gender. Lindgren
and colleagues [14] reported genome-wide significant
associations with WHR near LYPLAL1 at 1q41 among
women before adjusting for BMI (P = 2.6 × 10
-8), which
attenuated following BMI adjustment (P = 4.3 × 10
-6),
whereas the association among males was not statisti-
cally significant (P = 0.50). Associations were also seen
for BMI (P = 1.9 × 10
-4) and waist circumference (P =
0.01) at these loci among women but not for men [14].
The second GWAS reported associations with waist cir-
cumference for NRXN3 at 14q31 among women (P =
0.0005) and men (P = 0.001), which was no longer sta-
tistically significant following BMI adjustment [38].
These studies provide evidence that genetic determi-
nants of adiposity vary by sex, and support further
investigation of the GWAS candidates by menopausal
status.
Genes previously-reported to be associated with obesity
and that reside within marker intervals at our peak LOD
scores include GHRL, PPARG, HTR2A and ESR2 (Table
3). They influence appetite and the pathology of numer-
ous diseases including obesity [24,42-46]. Sowers and col-
leagues [24,42] reported findings that suggest changes in
ghrelin concentrations in thep e r i - m e n o p a u s em a yp r e -
cede increases in waist circumference. Ghrelin can stimu-
late feeding and body weight gain by neuroendocrine
Figure 1 Maximum LOD scores achieved for univariate linkage
to the BMI trait among pre-menopausal women.
Figure 2 Maximum LOD scores achieved for univariate linkage
to the hip circumference trait among pre-menopausal women
(A) and post-menopausal women (B).
Table 4 Bivariate multivariable-adjusted
a multipoint
linkage (LOD ≥ 3.0) at chromosomal regions with
obesity-related traits among pre-menopausal women.
Position Trait
b Peak LOD
score
Marker Peak LOD position
(cM)
2p23 BMI-HC 3.30 D2S165 47.90
2p23 BMI-
WHR
3.17 D2S165 48.47
3p26 BMI-HC 3.65 D3S1304 14.05
3p26 BMI-WC 3.00 D3S1304 14.83
11q22 BMI-HC 3.14 D11S898 104.45
13q13 BMI-HC 3.59 D13S218 40.88
13q13 HC-WHR 3.01 D13S218 41.47
13q14 BMI-HC 3.59 D13S263 40.88
13q14 HC-WHR 3.01 D13S263 41.47
13q14 WC-
WHR
3.00 D13S263 42.66
13q14 BMI-
WHR
3.28 D13S263 43.25
aAdjusted for age, parity, education, smoking, physical activity, and
oophorectomy. BMI was included in the models of waist circumference and
WHR, and of hip circumference and WHR.
bBMI, body mass index; WHR, waist to hip ratio; WC, waist circumference; HC,
hip circumference.
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causes a shift in fat distribution from visceral to subcuta-
neous fat, increases plasma adiponectin, decreases plasma
resistin and suppresses macrophage production of
inflammatory markers - all which result in improved
insulin sensitivity and glycemic control [43]. Treatment
with estrogen prevented intra-abdominal fat deposition
[26,27] and promoted fat oxidation in muscle through
up-regulation of PPARG expression [49]. If the absence
of estrogen leads to abdominal fat deposition, it is possi-
ble that reduced PPARG expression may act coopera-
tively to potentiate metabolic syndrome-related
symptoms that are often associated with increased waist
girth [44]. HTR2A encodes a serotonin receptor and sero-
tonin is a key mediator in the control of appetite, weight
regulation and body weight distribution [50] (also
reviewed in [45]). Low cerebrospinal fluid levels of sero-
tonin metabolites have been found in women with pri-
marily abdominal obesity [51]. Furthermore, serotonin
responsivity declines after menopause [52], and estrogen
treatment in post-menopausal women both decreases
brain 5-HT2A receptors [53] and prevents abdominal fat
deposition [26,27], possibly by restoring the sensitivity of
the receptors to circulating serotonin. Interestingly,
estrogen receptor beta (ERb) is the receptor responsible
for serotonergic neurotransmission in primates [46].
ESR2, which encodes ERb, is within the marker interval
at 14q23 that linked to hip circumference among post-
menopausal women in our study. In addition, our linkage
analysis identified novel regions and putative genes that
may also be associated with obesity-related phenotypes
including PI4KB, HAAO, CNTN4, GRM7, UFM1, RB1,
BOD1L, STARD4, EGLN3 and NRN1. Interestingly, some
of these genes appear to play a role in neurological
disorders [54], or neuronal development or signaling
[55-57], similar to those genes identified recently in the
GWAS [12,38].
Although our findings point to plausible genetic influ-
ences for obesity traits by menopausal status, this study
also has potential limitations. The findings were based
on a small sample size with a relatively small number of
g e n e t i cm a r k e r s .W er e d u c e dt h ep o s s i b i l i t yt h a te v i -
dence for linkage was due to a few families with extreme
phenotypes by ensuring the phenotypes were normally
distributed. Further, the genetic effect on phenotypes
such as BMI may decrease with age as one loses height
or muscle mass [39]. Ideally, serial measurements would
strengthen and serve to validate genetic analyses of
quantitative obesity-related phenotypes [58].
Conclusions
In summary, these results provide a genetic basis for fat
deposition that differs by menopausal status, and sug-
gests the same loci encode genes that influence general
obesity (BMI) and specifically hip circumference among
pre-menopausal women. However, lower heritability
among pre-menopausal women for waist circumference
and WHR suggests that pre-menopausal waist girth may
be influenced to a greater extent by controllable envir-
onmental factors than post-menopausal waist girth.
Although requiring confirmation, it is possible that tar-
geted interventions among pre-menopausal women may
prevent or attenuate post-menopausal abdominal weight
deposition. Future studies will need to disentangle the
precise mechanism(s) between the loci/genes reported
in this investigation with the environment to aid in our
understanding of obesity phenotypes among pre-meno-
pausal and post-menopausal women for chronic disease
prevention.
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